⌘K

Login Start Free

Home/Filings/4/0001104659-25-066420

4//SEC Filing

Smith Hunter C 4

Accession 0001104659-25-066420

CIK 0001649904other

View on SEC.gov Company Profile

Filed

Jul 7, 8:00 PM ET

Accepted

Jul 8, 4:30 PM ET

Size

7.0 KB

Accession

0001104659-25-066420

Insider Transaction Report

Form 4

Period: 2025-07-07

RHYTHM PHARMACEUTICALS, INC.RYTM

Chief Financial Officer

Transactions

Exercise/Conversion
Common Stock
2025-07-07$6.88/sh+6,986$48,064→ 116,915 total
Exercise/Conversion
Stock Options (Right to Buy)
2025-07-07−6,986→ 70,208 total
Exercise: $6.88Exp: 2027-08-08→ Common Stock (6,986 underlying)

Footnotes (1)

[F1]The stock option is fully vested.

Documents

1 file

4
tm2520047-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

RHYTHM PHARMACEUTICALS, INC.

CIK 0001649904

Entity typeother

Related Parties

1

filerCIK 0001636385

Filing Metadata

Form type: 4
Filed: Jul 7, 8:00 PM ET
Accepted: Jul 8, 4:30 PM ET
Size: 7.0 KB

View on SEC.gov